CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-20 | Valamehr Bahram Chief Development Officer | Grant or award · Stock Option (right to buy) | +6,851 | 6,851 | ||
| 2021-01-20 | TAHL CINDY General Counsel and Secretary | Grant or award | +18,013 | 108,048 | ||
| 2021-01-20 | TAHL CINDY General Counsel and Secretary | Grant or award · Stock Option (right to buy) | +6,851 | 6,851 | ||
| 2021-01-20 | Shoemaker Daniel D Chief Scientific Officer | Grant or award | +14,411 | 98,020 | ||
| 2021-01-20 | Shoemaker Daniel D Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +5,481 | 5,481 | ||
| 2021-01-20 | Dulac Edward J III Chief Financial Officer | Grant or award | +18,013 | 58,013 | ||
| 2021-01-20 | Dulac Edward J III Chief Financial Officer | Grant or award · Stock Option (right to buy) | +6,851 | 6,851 | ||
| 2021-01-19 | TAHL CINDY General Counsel and Secretary | Option exercise | +35,000 | $2.90 | $102K | 125,035 |
| 2021-01-19 | TAHL CINDY General Counsel and Secretary | Sale | −15,835 | $114.11 | $1.8M | 109,200 |
| 2021-01-19 | TAHL CINDY General Counsel and Secretary | Sale | −14,944 | $115.09 | $1.7M | 94,256 |
| 2021-01-19 | TAHL CINDY General Counsel and Secretary | Sale | −4,021 | $115.97 | $466K | 90,235 |
| 2021-01-19 | TAHL CINDY General Counsel and Secretary | Sale | −200 | $117.07 | $23K | 90,035 |
| 2021-01-19 | TAHL CINDY General Counsel and Secretary | Option exercise · Stock Option (right to buy) | −35,000 | 28,149 | ||
| 2021-01-11 | Wolchko J Scott President and CEO | Sale | −3,515 | $111.62 | $392K | 355,634 |
| 2021-01-11 | Wolchko J Scott President and CEO | Sale | −2,772 | $110.76 | $307K | 352,862 |
| 2021-01-11 | Wolchko J Scott President and CEO | Sale | −2,300 | $109.65 | $252K | 350,562 |
| 2021-01-11 | Valamehr Bahram Chief Development Officer | Sale | −1,332 | $111.62 | $149K | 79,649 |
| 2021-01-11 | Valamehr Bahram Chief Development Officer | Sale | −1,051 | $110.76 | $116K | 78,598 |
| 2021-01-11 | Valamehr Bahram Chief Development Officer | Sale | −871 | $109.65 | $96K | 77,727 |
| 2021-01-11 | TAHL CINDY General Counsel and Secretary | Sale | −1,332 | $111.62 | $149K | 91,957 |
Page 24 of 26 · 503 trades